Geistlich Bio-Gide® Portfolio Expands

16-04-2018

The Collagen Expert, Geistlich Biomaterials Launches Two NEW Resorbable Collagen Membranes to Enhance Clinical Procedures 

Geistlich Pharma North America, Inc., introduces Geistlich Bio-Gide® Compressed and Geistlich Bio-Gide® Shape to its portfolio of resorbable collagen membranes.

Geistlich Bio-Gide® Compressed and Geistlich Bio-Gide® Shape were developed with the same biological properties and predictable results as the leading collagen membrane for oral tissue regeneration, Geistlich Bio-Gide®1,2. Geistlich Bio-Gide® Compressed, with a smoother surface, firmer feel and easier cutting characteristics,  was designed by our collagen experts to suit personal handling preferences. Geistlich Bio-Gide® Shape is pre-cut and designed for the treatment of non-intact extraction sockets. Both membranes provide a slower absorption time allowing for accurate positioning of the membranes into defects.

"Geistlich Bio-Gide® Compressed combines alternative handling with the proven outstanding biofunctionality of Geistlich biomaterials, allowing surgeons more choice for their membranes," said Dr. István Urbán.

"Geistlich Bio-Gide® Shape is a user-friendly, resorbable collagen membrane that can easily be implemented in the management of post-extraction sites for ridge preservation," expalined Dr. Daniele Cardaropoli.

Indications for Use
Geistlich Bio-Gide® Compressed is indicated for the following uses: Augmentation around implants placed in immediate or delayed extraction sockets, localised ridge augmentation for later implantation, alveolar ridge reconstruction for prosthetic treatment, filling of bone defects after root resection, cystectomy and removal of retained teeth, guided bone regeneration in dehiscence defects and guided tissue regeneration procedures in periodontal defects.

Geistlich Bio-Gide® Shape is indicated for the following uses: Augmentation around implants placed in immediate or delayed extraction sockets; localised ridge augmentation for later implantation; alveolar ridge reconstruction for prosthetic treatment; filling of bone defects after root resection; cystectomy and removal of retained teeth and guided bone regeneration in dehiscence defects.

References

1.iData Research Inc., US Dental Bone Graft Substitutes and other Biomaterials Market, 2011.

2.iData Inc., European Dental Bone Graft Substitutes and other Biomaterials Market, 2012.